Pinsent Masons appoints prominent Life Sciences partner in London

02 Nov 2021 | 03:00 pm | 1 min. read

Multinational law firm Pinsent Masons has recruited partner Dr Gareth Morgan to its European Life Sciences team, further strengthening its technology, science and industry (TSI) sector capabilities.

Gareth, who joins from CMS, is a market-leading pharma patent and medicines regulatory specialist, with significant experience in all areas of contentious and non-contentious intellectual property (IP) law. He has acted in many landmark UK IP trials concerning patent entitlement, pharmaceutical and biotechnology patent validity and infringement, SPCs and the interpretation of IP licences.

Joining the firm’s London office, he brings with him a team of five lawyers who will all work closely with partner Catherine Drew to expand the firm’s medicine regulatory litigation offering.

With a PhD in molecular biology, Gareth is passionate about the life sciences sector and joins a full-service team where many hold relevant scientific qualifications and degrees, including in genetics, medicinal chemistry, human biology, and biochemistry.

Head of IP & Life Sciences Clare Tunstall said:

"The needs of our life sciences clients are continuously evolving, and we need to ensure that we can support them across all business-critical areas. The appointment of Gareth will significantly bolster our ability to service our international client base, particularly in respect of medicine regulatory and patent litigation work where we are seeing a growing demand across our European business".

Head of technology, science & industry Florian von Baum added:

"Gareth’s reputation precedes him; he is a market leading international practitioner with deep sector knowledge and will add invaluable strength to our team. His appointment bolsters key proficiencies across our multinational team.”

Gareth’s hire follows the recent appointment of life sciences partners Gina Bicknell in London and Machteld Hiemstra in Amsterdam.

Key Contacts

Clare Tunstall

Clare Tunstall

Partner, Head of IP & Life sciences

View Profile

Latest press releases

Show me all press releases

Pinsent Masons advises Fluence on successful bid to build Australian battery energy storage system

Multinational law firm Pinsent Masons has advised leading global provider of energy storage products and services, and optimisation software for renewables and storage Fluence Energy, Inc. on its successful bid to build the Latrobe Valley Battery Energy Storage System (BESS) in Victoria.

Pinsent Masons advises Bestinver Infra FCR on Irish toll road share purchase deal

Multinational law firm Pinsent Masons has advised Bestinver Infra, FCR, on the acquisition of an interest in N6 (Concession) Holdings Limited and N6 (Operations) Limited from Sacyr Concessions Limited.

Pinsent Masons named Most Innovative Law Firm in Europe 2023 by Financial Times

Multinational law firm Pinsent Masons has been named the Most Innovative Law Firm in Europe and won the Energy & Security Transition category at this year’s FT Innovative Lawyer Awards.

People who viewed this press release also viewed

Show me all press releases

Pinsent Masons hires Life Science partner in Dublin

Multinational law firm Pinsent Masons has hired transactional life sciences specialist Michael Stewart as partner in its Dublin office as it expands its pan-European Technology, Science and Industry (TSI) capabilities.

Pinsent Masons hires Corporate Partner Camille Chiari in Paris

Multinational law firm Pinsent Masons has hired Corporate Partner Camille Chiari who joined the firm’s Paris Office.

Pinsent Masons appoints leading patent litigation partner in its London office

Multinational law firm Pinsent Masons has hired patent litigation partner James Marshall to join its London office.

For all media enquiries, including arranging an interview with one of our spokespeople, please contact the press office on

+44 (0)20 7418 8199 or 

Location contacts

We are processing your request. \n Thank you for your patience. An error occurred. This could be due to inactivity on the page - please try again.